These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24400786

  • 61. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 62. [The investigation of tranilast on the proliferation and migration of human Tenon's capsule fibroblasts].
    Ji CN, Hu YZ, Ding ZP, Li GG.
    Zhonghua Yan Ke Za Zhi; 2004 Mar; 40(3):165-9. PubMed ID: 15307986
    [Abstract] [Full Text] [Related]

  • 63. Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.
    Kim YH, Jung JC, Gum SI, Park SB, Ma JY, Kim YI, Lee KW, Park YJ.
    PLoS One; 2017 Mar; 12(1):e0169675. PubMed ID: 28068383
    [Abstract] [Full Text] [Related]

  • 64. Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients.
    Zanotti S, Mora M.
    Methods Mol Biol; 2018 Mar; 1687():205-217. PubMed ID: 29067666
    [Abstract] [Full Text] [Related]

  • 65. Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes.
    Nakanishi H, Kaibori M, Teshima S, Yoshida H, Kwon AH, Kamiyama Y, Nishizawa M, Ito S, Okumura T.
    J Hepatol; 2004 Nov; 41(5):730-6. PubMed ID: 15519644
    [Abstract] [Full Text] [Related]

  • 66. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
    Zhou H, Latham CW, Zander DS, Margolin SB, Visner GA.
    J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
    [Abstract] [Full Text] [Related]

  • 67. Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.
    Meier R, Lutz C, Cosín-Roger J, Fagagnini S, Bollmann G, Hünerwadel A, Mamie C, Lang S, Tchouboukov A, Weber FE, Weber A, Rogler G, Hausmann M.
    Inflamm Bowel Dis; 2016 Mar; 22(3):569-82. PubMed ID: 26848518
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stents.
    Walter RF, Zarogoulidis P, Mairinger FD, Werner R, Darwiche K, Zarogoulidis K, Freitag L.
    Int J Pharm; 2014 May 15; 466(1-2):38-43. PubMed ID: 24607204
    [Abstract] [Full Text] [Related]

  • 70. Pirfenidone prevents capsular contracture after mammary implantation.
    Gancedo M, Ruiz-Corro L, Salazar-Montes A, Rincón AR, Armendáriz-Borunda J.
    Aesthetic Plast Surg; 2008 Jan 15; 32(1):32-40. PubMed ID: 17968613
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Baseline expression and effect of TGF-beta 1 on type I and III collagen mRNA and protein synthesis in human odontoblasts and pulp cells in vitro.
    Palosaari H, Tasanen K, Risteli J, Larmas M, Salo T, Tjäderhane L.
    Calcif Tissue Int; 2001 Feb 15; 68(2):122-9. PubMed ID: 11310348
    [Abstract] [Full Text] [Related]

  • 73. Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics.
    Peiretti E, Dessì S, Mulas MF, Abete C, Galantuomo MS, Fossarello M.
    Exp Eye Res; 2006 Sep 15; 83(3):536-42. PubMed ID: 16696971
    [Abstract] [Full Text] [Related]

  • 74. [Fibroblasts from recurrent pterygium and normal Tenon's capsule exposed to tacrolimus (FK-506)].
    Carvalho CS, Viveiros MM, Schellini SA, Candeias JM, Padovani CR.
    Arq Bras Oftalmol; 2007 Sep 15; 70(2):235-8. PubMed ID: 17589693
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane.
    Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC.
    Curr Eye Res; 2000 Apr 15; 20(4):325-34. PubMed ID: 10806447
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. The experimental agent pirfenidone reduces pro-fibrotic gene expression in a model of tacrolimus-induced nephrotoxicity.
    Brook NR, Waller JR, Bicknell GR, Nicholson ML.
    J Surg Res; 2005 May 15; 125(2):137-43. PubMed ID: 15854665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.